Status:
WITHDRAWN
Validation of Transesophageal Echocardiography (TEE) to Measure Renal Resistive Index and to Predict Renal Injury
Lead Sponsor:
University of Medicine and Dentistry of New Jersey
Conditions:
Decreased Vascular Flow to Kidneys
Eligibility:
All Genders
18-89 years
Brief Summary
The study doctors are trying to determine if the TEE measurements from your stomach are helpful in measuring the blood flow to the kidneys.
Detailed Description
The significant morbidity and mortality associated with acute kidney injury in critical care patients and after cardiac surgery is well-known. Studies have demonstrated between 1 to 30% postoperative ...
Eligibility Criteria
Inclusion
- Subjects with use of TEE as part of anesthetic plan as clinically determined by anesthesiologist
- Subjects with no contraindications to use of TEE or transabdominal doppler ultrasonography
Exclusion
- Patients on hemodialysis/peritoneal dialysis
- Patients with a contraindication to use of TEE i.e.esophageal stricture, esophageal diverticulum, esophageal/gastric tumor, recent esophageal/gastric surgery or radiation to the chest
- Patients with a contraindication to use of transabdominal doppler ultrasonography
- Patients who are pregnant
- patients with esophageal varices
- Patient with bleeding disorders
Key Trial Info
Start Date :
May 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01151774
Start Date
May 1 2010
End Date
June 1 2011
Last Update
February 2 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Newark, New Jersey, United States, 07101